Brian O'Nuallain

Brian O'Nuallain currently serves as the Director and Head of In Vitro Discovery and External Innovation at Leveragen since January 2024. Prior experience includes roles as Director and Head of In Vitro Discovery at Alloy Therapeutics, Inc. from June 2021 to October 2023, and Senior Principal Scientist at Immunitas Therapeutics from August 2020 to June 2021. Brian has also held senior scientist positions at Verseau Therapeutics and BioLegend, with a focus on neurodegenerative protein aggregation and clearance. Previous academic appointments include Assistant Professor at Harvard Medical School and Assistant Professor at UT Medical Center. Brian earned a Ph.D. in Biochemistry from University College Dublin, with multiple degrees in the same field from the same institution.